Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. - Test2 - elhamkhani - TriplyDB

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

http://www.wikidata.org/entity/Q33186765

about

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy Immunologic aspect of ovarian cancer and p53 as tumor antigen.PD-L1 expression in human cancers and its association with clinical outcomes Melanoma immunotherapy dominates the field New targeted treatments for non-small-cell lung cancer - role of nivolumab Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications Metabolism Is Central to Tolerogenic Dendritic Cell Function PD-1/PD-L1 blockade in cancer treatment: perspectives and issues Novel immunotherapies in lymphoid malignancies Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy The Promise of Preventive Cancer Vaccines Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity Overcoming T cell exhaustion in infection and cancer Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer Tumor-infiltrating dendritic cells in cancer pathogenesis From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer Tumor infiltrating lymphocytes in ovarian cancer Checkpoint modulation--A new way to direct the immune system against renal cell carcinoma B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections The blockade of immune checkpoints in cancer immunotherapy Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations Immune checkpoint therapy for pancreatic cancer Immune checkpoint blockade: a common denominator approach to cancer therapy PD-L1 and Survival in Solid Tumors: A Meta-Analysis Anti-programmed death receptor 1 immunotherapy in melanoma: rationale, evidence and clinical potential Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy From mice to humans: developments in cancer immunoediting

P2860

Q24672476-D41E8E0D-A2C0-46DA-A219-48EE65D66171 Q24676809-72C45861-59D7-4351-A7BD-43DE5FA87AC4 Q24685406-3C5B06E8-AD48-4911-93E8-EC160591D950 Q24796946-3324282A-224C-4492-9D34-7D5BE2B91301 Q24798754-4D648845-8203-4E1C-9DE8-E91B31556BB1 Q24814703-5166326C-D0B9-4DB5-AA11-299B9ACD445E Q26738361-9CF2340F-6F72-4F98-8266-8368F7DA04CC Q26738671-525C03C7-5330-4BD8-B911-7A0D5B4FC92C Q26740988-80D1C56C-0353-487F-8445-65CCE5E28D4D Q26744527-397DD149-D972-4596-A5BA-5EB6F88AA1C4 Q26745516-C9DF830C-8478-4032-8B96-5C9F0A89C578 Q26749333-025E00FC-EB9E-4A7A-A74B-743B3B4C4652 Q26764855-0E226D1C-9BB7-4C44-B1BF-230B7C510E16 Q26765348-59ACA7E4-E49D-4E78-957D-9B52327DE366 Q26768641-871EAC6A-8FC9-42B4-9D1A-6B362471C4B6 Q26777394-0BD3F9E8-3A05-4586-96B5-E7FF1119CA79 Q26779184-6619B96F-3449-47CC-AA78-07D8AD61A88F Q26781481-08A8672E-4422-474B-BDA4-02F0EF8362B3 Q26783742-3F7535F8-825D-44A9-92BD-524FDF5468C7 Q26798047-CAE19AB0-2467-4A81-9378-31C95EDEC36B Q26829847-B830C786-8ACE-4BE4-A53C-5A2C92DA9EE7 Q26829885-E8DC2FD5-8D3F-40B6-B4AF-FB6A0A836211 Q26861293-5B834F3D-48D9-44BE-84B2-6BC0EA6C27E0 Q26861633-A11C7454-0B85-4C12-952A-11B62762BBB2 Q26865532-119D2204-330F-43B2-A92B-1762DEDF1263 Q26996518-4EDDA519-B8D6-49FD-9DAB-1E5D47CCFAF5 Q26996829-08F84C06-085A-4CBF-B50A-9054329B8BE0 Q27021878-72608C46-3FCE-4E40-9F30-001D8B17206A Q27025873-08FFEA27-63A4-43FD-80A2-07F59C782211 Q27317015-EB47FF1B-22FC-4E2E-91AE-96752A7C3ADB Q27860852-BCF100E9-D72A-4989-9E42-089FBC69CEDF Q27860857-B7C8BD89-5B29-4C2F-ADDA-667E81C388FB Q28075712-A6DE6678-AF95-462B-B8B2-EAAEFD0D3DC7 Q28078390-46F5EFEF-558C-493E-8EFA-54ECD9B9ED36 Q28083981-F8C9E903-110B-4C59-8085-EA1F0D36215D Q28084090-70F312FD-1DBE-418B-9DA0-91FE38A88884 Q28084942-3124A7FA-C72A-4FB7-A4B3-9BEECE6A64A5 Q28085029-A6BE0C4A-648F-42F6-929E-DBC14CC2F8D2 Q28087576-68AEE077-D593-41A3-AED0-C60B7C0E10DF Q28088304-F5668AA5-2B79-4568-9A28-5DDDA0139298

P2860

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

http://www.wikidata.org/entity/Q33186765

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

@ast

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

@en

type

label

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

@ast

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

@en

prefLabel

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

@ast

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

@en

P1433

Q33186765-5A0293AC-A5F8-4786-982E-B8EFE5E0BD52

P1476

Q33186765-CF6E50FF-E7F0-4CC4-ACEB-2B950AAE4028

P2093

Q33186765-02E497D0-3B4D-485B-B031-FC495F87CE3D

Q33186765-076C86BF-57D7-4A57-9A9D-F63EAA1FA509

Q33186765-133DDB9A-C7C5-4C71-8C52-E3AFBD7C4C0A

Q33186765-37A91B42-C2A5-4D83-9762-2B684EA44810

Q33186765-4CE6548A-CB22-4BA6-AAB2-D8E7B81AFFE6

Q33186765-52D9DA08-9D51-4CC5-B44B-A3A45D5282E6

Q33186765-7EA11B99-4E56-4C71-AD5C-6D2BB3C2A0C6

Q33186765-813911E3-9FFA-47C6-8211-84F1B9006B77

Q33186765-9E151A64-9DE5-4AF8-BA91-6A776FEB4BD7

Q33186765-B04B5314-B097-4FD0-979D-6BDC630CC5F9

P2888

Q33186765-750014F8-9C01-48EE-8E19-4503DC3DFB75

P304

Q33186765-2F6A0D72-6ED7-447A-BE30-7BA3DD4E3FC3

P31

Q33186765-5BEF93B1-4C65-4B2E-A0AA-587502723960

P356

Q33186765-8905F5F8-B020-4A9F-B510-476C104D3F92

P407

Q33186765-22307F79-4470-46F9-AA47-22BF9BEF0A37

P433

Q33186765-3918866E-DD91-416E-BBEE-6946349BF6F1

P478

Q33186765-AE889254-5CFE-4631-975E-E6FEBFCBA7F2

P50

Q33186765-24BA1A7F-C997-4B51-8BCB-0CAD417239A0

Q33186765-77096900-7C2A-4E72-AC80-31601DF94F76

P577

Q33186765-A0583FDD-8C27-457E-BDFF-954574608E1E

P5875

Q33186765-22A726B0-CC49-450B-AC27-0A60713B49EF

P698

Q33186765-04CFAF3F-901C-41FB-B345-4EAFF725406D

P356

P1433

Nature Medicine

P1476

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

@en

P2093

Alan Gordon

http://www.w3.org/2001/XMLSchema#string

Ben Daniel

http://www.w3.org/2001/XMLSchema#string

Dominique Emilie

http://www.w3.org/2001/XMLSchema#string

Haidong Dong

http://www.w3.org/2001/XMLSchema#string

Keith L Knutson

http://www.w3.org/2001/XMLSchema#string

Leann Myers

http://www.w3.org/2001/XMLSchema#string

Lieping Chen

http://www.w3.org/2001/XMLSchema#string

Maria Carla Zimmermann

http://www.w3.org/2001/XMLSchema#string

Matthew Burow

http://www.w3.org/2001/XMLSchema#string

Nina Dhurandhar

http://www.w3.org/2001/XMLSchema#string

P2888

P304

562-567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM863

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Akseli Hemminki

David T. Curiel

P577

2003-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7468474

http://www.w3.org/2001/XMLSchema#string

P698

12704383

http://www.w3.org/2001/XMLSchema#string